Genetic Signatures
Business Services · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7 Eliza St, Newtown, New South Wales, 20...Phone Number
+61 298707580Website
www.geneticsignatures.comRevenue
$6.1 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Genetic Signatures
Genetic Signatures, founded in 2001 and headquartered in Australia, is a biotechnology research and development company that specializes in molecular diagnostic solutions. The company develops and manufactures the EasyScreen Pathogen Detection Kits based on their proprietary 3base technology. These diagnostic tools enable hospitals and pathology laboratories to efficiently screen for multiple infectious pathogens in a high-throughput environment. As a publicly traded company since 2019, Genetic Signatures serves both business and consumer markets across Australia, Europe, and other global regions with their innovative molecular testing solutions.Explore more
Genetic Signatures Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Genetic Signatures your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Genetic Signatures is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Genetic Signatures has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Genetic Signatures
Earning: See what the market has to say on Genetic Signatures recently announced quarterly report
Genetic Signatures, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Genetic Signatures had a recent Job posting/layoffs
Check if Genetic Signatures has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Genetic Signatures launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Genetic Signatures
Compare insights from companies similar to Genetic Signatures, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Genetic Signatures is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Genetic Signatures is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Genetic Signatures.
Genetic Signatures Tech Stack
A closer look at the technologies used by Genetic Signatures
Most Recent Scoops
Open Position
Left Company
Executive Move
Executive Moves, Left Company
Open Position
Seeking Replacement
Left Company
Executive Move
Executive Moves, Left Company
Open Position
Genetic Signatures News & Media
Genetic Signatures Limited (ASX:GSS) is definitely on the radar of institutional investors who own 44% of the company
Key Insights Given the large stake in the stock by institutions, Genetic Signatures' stock price might be vulnerable to...FDA Clearance For Gastrointestinal Parasite Detection Kit
MELBOURNE, Australia, June 4, 2024 /PRNewswire/ -- Genetic Signatures Limited [ASX:GSS] ("GSS" or the "Company"), a global molecular diagnostics company announces that the US Food & Drug Administration ("FDA") has cleared the Company's EasyScreen™ Gastrointestinal Parasite Detection Kit and GS1 automated workflow[1] for marketing and sale in the US. Genetic Signatures' EasyScreen™ Gastrointestinal Parasite Detection Kit has the broadest coverage of the FDA cleared molecular tests and is able toChris Abbott-backed Genetic Signatures raises $30 million - AFR
There’s an FDA approval in the bag, and a CEO replacement for long-standing boss John Melki has been found. And of course, the stock is up 78 per cent year to date.Shareholders in Genetic Signatures (ASX:GSS) are in the red if they invested three years ago
Genetic Signatures Limited ( ASX:GSS ) shareholders should be happy to see the share price up 13% in the last month...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Genetic Signatures
Sign Up For FreeTo access detailed company insights
Genetic Signatures, founded in 2001 and headquartered in Australia, is a biotechnology research and development company that specializes in molecular diagnostic solutions. The company develops and manufactures the EasyScreen Pathogen Detection Kits based on their proprietary 3base technology. These diagnostic tools enable hospitals and pathology la... Read More
